Muñoz-Torrero D.
89
Coauthors
6
Documentos
Volumen de publicaciones por año
Cargando gráfico
| Año de publicación | Num. Publicaciones |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
| Área de conocimiento | Num. Publicaciones |
|---|---|
| Neurología | 4 |
| Farmacología | 4 |
| Descubrimiento de fármacos | 3 |
| Neuropsicología | 2 |
| Bioquímica | 2 |
Publicaciones por áreas temáticas
Cargando gráfico
| Área temática | Num. Publicaciones |
|---|---|
| Farmacología y terapéutica | 6 |
| Enfermedades | 5 |
| Fisiología humana | 2 |
| Química y ciencias afines | 1 |
| Fisiología y materias afines | 1 |
Principales fuentes de datos
| Origen | Num. Publicaciones |
|---|---|
| Scopus | 6 |
| Google Scholar | 0 |
| RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
| Coautor | Num. Publicaciones |
|---|---|
| Antoni Camins | 6 |
| Pallás M. | 4 |
| Verdaguer E. | 4 |
| Camps P. | 4 |
| Bartolini M. | 3 |
| Andrisano V. | 3 |
| Viayna E. | 3 |
| Canudas A.M. | 2 |
| Jiménez A. | 2 |
| Sanchez-Lopez E. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
(±)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration
ArticleAbstract: Acetylcholinesterase inhibitors (AChEI) are among the drugs most widely used in the treatment of AlzPalabras claves:acetylcholinesterase inhibitors, Cerebellar granule cells, colchicine, neuronal death, RATAutores:Antoni Camins, Camps P., Canudas A.M., Jiménez A., Jordá E.G., Muñoz-Torrero D., Pallás M., Rimbau V., Verdaguer E.Fuentes:scopusNeuroprotective effects of (±)-huprine Y on in vitro and in vivo models of excitoxicity damage
ArticleAbstract: We have investigated the neuroprotective effects of (±)-huprine Y on excitotoxic lesions in rat cerePalabras claves:3-nitropropionic acid, Cerebellar granule cells, glutamate, Huprines, neuroprotectionAutores:Antoni Camins, Camps P., Canudas A.M., Jiménez A., Muñoz-Torrero D., Pallás M., Pubill D., Sureda F.X., Verdaguer E.Fuentes:scopusA novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
ArticleAbstract: Background: Alzheimer’s disease (AD) is characterized by a polyetiological origin. Despite the globaPalabras claves:Alzheimer’s disease, BACE1, BDNF, cognitive decline, dendritic spines, high-fat diet, neuroinflammation, Rhein-huprine hybrid, Tau, TLR4Autores:Antoni Camins, Auladell C., Bulló M., Cano A., Espinosa-Jimenez T., Ettcheto M., Folch J., Muñoz-Torrero D., Olloquequi J., Parcerisas A., Pont C., Sanchez-Lopez E., Verdaguer E.Fuentes:scopusNovel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation
ArticleAbstract: A novel series of donepezil-tacrine hybrids designed to simultaneously interact with the active, perPalabras claves:Autores:Andrisano V., Antoni Camins, Badia A., Bartolini M., Bidon-Chanal A., Camps P., Clos M.V., Estelrich J., Formosa X., Galdeano C., Gómez T., Lizondo M., Luque F.J., Mancini F., Muñoz-Torrero D., Pallás M., Scarpellini M., Viayna E.Fuentes:scopusNovel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates
ArticleAbstract: A new family of dual binding site acetylcholinesterase (AChE) inhibitors has been designed, synthesiPalabras claves:Acetylcholinesterase, drug design, Inhibitors, β-amyloid peptides, β-secretaseAutores:Andrisano V., Antoni Camins, Arce M.P., Badia A., Bartolini M., Bidon-Chanal A., Camps P., Clos M.V., Galdeano C., Gómez T., Junyent F., Luque F.J., Mancini F., Muñoz-Torrero D., Pallás M., Ramírez L., Ratia M., Rodríguez-Franco M.I., Verdaguer E., Viayna E.Fuentes:scopus